MEROXOBIL-1 GM: High-Potency Meropenem 1000 mg Injection for Severe & Resistant Bacterial Infections

Introduction

MEROXOBIL-1 GM is a premium broad-spectrum carbapenem antibiotic injection from Amcare Biosciences, specially formulated for the treatment of severe, life-threatening, and resistant bacterial infections.
This formulation contains:

• Sterile Meropenem Trihydrate IP (sterile) equivalent to Anhydrous Meropenem 1000 mg

• Sterile Sodium Carbonate IP (sterile) equivalent to Sodium 90.2 mg (as buffer)

Meropenem, one of the most advanced injectable antibiotics, offers exceptional coverage against multi-drug–resistant pathogens, making MEROXOBIL-1 GM ideal for critical care and hospital settings.

What is MEROXOBIL-1 GM?

1. Meropenem Trihydrate IP

Equivalent to Anhydrous Meropenem 1000 mg

• A powerful carbapenem-class broad-spectrum antibiotic

• Highly effective against gram-positive, gram-negative, and anaerobic bacteria

• One of the most potent options for severe hospital-acquired infections

• Inhibits bacterial cell wall synthesis through strong β-lactam binding

• Effective even against ESBL, MDR strains, and resistant organisms

2. Sodium Carbonate IP

Equivalent to Sodium 90.2 mg (as buffer)

• Helps maintain stability of Meropenem

• Ensures proper reconstitution

• Maintains pH balance for safe administration

Key Benefits of MEROXOBIL-1 GM

✔ Strongest broad-spectrum antibacterial coverage
✔ Effective against multi-drug–resistant (MDR) & hospital-acquired pathogens
✔ Rapid bactericidal action with high clinical success rates
✔ Suitable for severe and life-threatening infections
✔ Manufactured under strict sterile IP standards
✔ Trusted by critical care specialists and hospitals

Indications

MEROXOBIL-1 GM is commonly prescribed for:

• Hospital-acquired pneumonia (HAP/VAP)

• Complicated urinary tract infections (cUTIs)

• Intra-abdominal infections

• Complicated skin & soft tissue infections

• Meningitis

• Septicemia & bloodstream infections

• Gynecological infections

• Post-operative & ICU infections

• Resistant and mixed bacterial infections

How MEROXOBIL-1 GM Works

Meropenem 1000 mg

• Inhibits bacterial cell wall formation

• Shows strong binding to penicillin-binding proteins

• Effective against ESBL-producing & resistant strains

• Works on gram-positive, gram-negative, and anaerobic organisms

This ensures rapid bacterial killing, superior infection control, and robust patient recovery—especially in critical conditions.

Possible Side Effects

Common:

• Injection site pain

• Headache

• Nausea

• Diarrhea

Rare:

• Hypersensitivity reactions

• Seizures (in predisposed patients)

• Increased liver enzymes

Note: Administer only under medical supervision, preferably in hospital or emergency care settings.

Amcare Biosciences – Trusted PCD Pharma Company in Gujarat

Amcare Biosciences is a leading PCD Pharma Company in Gujarat, offering a strong portfolio across pharmaceutical, ayurvedic, nutraceutical, and cosmetic segments.
Premium brands like MEROXOBIL-1 GM, CEFXOBEES series, PIXTAZOX, TUZOF-S, CILNIBIL, LINABEES, and EMPAWITH demonstrate our commitment to high-quality and reliable healthcare solutions.

We also provide profitable PCD Pharma Franchise opportunities, supported by strong quality assurance and excellent product availability.

Conclusion

MEROXOBIL-1 GM, containing Meropenem 1000 mg with Sodium Carbonate buffer, is a powerful and reliable carbapenem antibiotic for treating severe and resistant bacterial infections.
Backed by the trusted quality standards of Amcare Biosciences, it ensures faster recovery, high safety, and superior clinical outcomes in critical-care patients.